Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 32, Issue 9, 2003, Pages 947-952

  Lee, J J ^a   Nam, C E ^a   Kook, H ^a   Maciejewski, J P ^b   Kim, Y K ^a   Chung, I J ^a   Park, K S ^a   Lee, I K ^a   Hwang, T J ^a   Kim, H Joon ^a  

^a Chonnam National University Medical School   (South Korea)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Mesenchymal stem cell; Telomere

Indexed keywords

BUSULFAN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; MICROSATELLITE DNA; PROCARBAZINE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BONE MARROW CULTURE; CHILD; CHIMERA; CHROMOSOME SATELLITE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DONOR; DYNAMICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; SOUTHERN BLOTTING; TELOMERE; WHOLE BODY RADIATION; X CHROMOSOME;

ADOLESCENT; ADULT; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; FEMALE; GENOTYPE; HEMATOLOGIC DISEASES; HUMANS; MALE; MESENCHYMAL STEM CELLS; STROMAL CELLS; TELOMERE; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 10744231679     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704253     Document Type: Article

References (34)

1. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57-66.
2. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-884.
3. Chamberlin W, Barone J, Kedo A, Fried W. Lack of recovery of murine hematopoietic stromal cells after irradiation-induced damage. Blood 1974; 44: 385-392.
4. Fried W, Chamberlin W, Kedo A, Barone J. Effects of radiation on hematopoietic stroma. Exp Hematol 1976; 4: 310-314.
5. Carlo-Stella C, Tabilio A, Regazzi E et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1997; 20: 465-471.
6. Domenech J, Roingeard F, Binet C. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation. Leukemia Lymphoma 1997; 24: 239-256.
7. O'Flaherty E, Sparrow R, Szer J. Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplant 1995; 15: 207-212.
8. Galotto M, Berisso G, Delfino L et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999; 27: 1460 1466.
9. Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol 2000; 7: 358-363.
10. Koc ON, Lazarus HM. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 2001; 27: 235-239.
11. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 1987; 328: 429-432.
12. Koc ON, Peters C, Aubourg P et al. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 1999; 27: 1675-1681.
13. Awaya N, Rupert K, Bryant E, Torok-Storb B. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol 2002; 30: 937-942.
14. Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest 2000; 105: 1663-1668.
15. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309 313.
16. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
17. Zakian VA. Telomeres: beginning to understand the end. Science 1995; 270: 1601-1607.
18. Moyzis RK, Buckingham JM, Cram LS et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6626.
19. Blackburn EH. Telomeres: no end in sight. Cell 1994; 77: 621-623.
20. Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860.
21. Shay JW. Accelerated telomere shortening in bone-marrow recipients. Lancet 1998; 351: 153-154.
22. Wynn RF, Cross MA, Hatton C et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998; 351: 178-181.
23. Lee J, Kook H, Chung I et al. Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 1999; 24: 411-415.
24. Rufer N, Brummendorf TH, Chapuis B et al. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 2001; 97: 575-577.
25. Lee JJ, Kook H, Chung U et al. Telomere length changes in patients with aplastic anaemia. Br J Haematol 2001; 112: 1025-1030.
26. Laver J, Jhanwar SC, O'Reilly RJ, Castro-Malaspina H. Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation. Blood 1987; 70: 1966 1968.
27. Agematsu K, Nakahori Y. Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans. Br J Haematol 1991; 79: 359-365.
28. Gordon MY. The origin of stromal cells in patients treated by bone marrow transplantation. Bone Marrow Transplant 1988; 3: 247-251.
29. Santucci MA, Trabetti E, Martinelli G et al. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1992; 10: 255-259.
30. Klyushnenkova E, Shustova V, Mosca J et al. Human mesenchymal stem cells induce unresponsiveness in preactivated but not naive alloantigen-specific T cells. Exp Hematol 1999; 27: a122.
31. Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307-316.
32. Horwitz E, Gordon P, Koo W et al. Transplanted gene-marked marrow mesenchymal stem cells engraft and benefit children with severe osteogenesis imperfecta: a pilot trial for cell and gene therapy of mesenchymal disorders. Mol Ther 2000; 1: s279.
33. Koc ON, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222.
34. Iwama H, Ohyashiki K, Ohyashiki JH et al. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet 1998; 102: 397-402.